Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recakimab for Lorlatinib-Induced Hypercholesterolemia
NCT07674368Phase 4Not yet recruiting
- Sponsor
- Hunan Cancer Hospital
- Start
- Jul 2026
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
A Phase 4 trial of recaticimab in hypercholesterolemia, sponsored by Hunan Cancer Hospital. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
recaticimab
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT07674368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07674368.